IRIS
DE VITO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
SA - Sud America 1.479
NA - Nord America 1.212
AS - Asia 1.138
EU - Europa 826
AF - Africa 66
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 4.731
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 1.366
US - Stati Uniti d'America 1.142
SG - Singapore 516
HK - Hong Kong 288
IT - Italia 246
DE - Germania 220
FI - Finlandia 105
CN - Cina 103
UA - Ucraina 42
AR - Argentina 39
TR - Turchia 36
RU - Federazione Russa 33
BD - Bangladesh 28
FR - Francia 28
MX - Messico 27
GB - Regno Unito 25
CZ - Repubblica Ceca 24
VE - Venezuela 24
CA - Canada 21
EC - Ecuador 21
IQ - Iraq 19
MA - Marocco 18
PK - Pakistan 18
UZ - Uzbekistan 17
ZA - Sudafrica 17
AT - Austria 16
KR - Corea 16
AE - Emirati Arabi Uniti 10
BE - Belgio 10
IL - Israele 10
CO - Colombia 9
KG - Kirghizistan 9
RO - Romania 9
AZ - Azerbaigian 8
NP - Nepal 8
RS - Serbia 8
TN - Tunisia 8
UY - Uruguay 8
DO - Repubblica Dominicana 7
IE - Irlanda 7
JM - Giamaica 7
PS - Palestinian Territory 7
JO - Giordania 6
LT - Lituania 6
BG - Bulgaria 5
EG - Egitto 5
HU - Ungheria 5
KE - Kenya 5
PE - Perù 5
SE - Svezia 5
AU - Australia 4
GE - Georgia 4
IN - India 4
KZ - Kazakistan 4
NL - Olanda 4
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AM - Armenia 3
BY - Bielorussia 3
DZ - Algeria 3
GR - Grecia 3
ID - Indonesia 3
LB - Libano 3
OM - Oman 3
PA - Panama 3
PY - Paraguay 3
BN - Brunei Darussalam 2
BO - Bolivia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CL - Cile 2
ES - Italia 2
HN - Honduras 2
JP - Giappone 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
MK - Macedonia 2
MT - Malta 2
MZ - Mozambico 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CR - Costa Rica 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
ML - Mali 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
Totale 4.730
Salva come PNG Salva come JPEG
Città #
Chandler 345
Singapore 289
Hong Kong 285
New York 179
Munich 131
Helsinki 91
São Paulo 79
Princeton 68
Sassari 61
Rio de Janeiro 53
Shanghai 52
Belo Horizonte 45
Brasília 30
Boardman 25
Brno 24
Santa Clara 24
Curitiba 23
Ashburn 21
Frankfurt am Main 20
Rome 20
Fortaleza 17
Salvador 17
Campinas 16
Seoul 16
Wilmington 16
Falkenstein 15
Nuremberg 15
Guarulhos 14
Porto Alegre 14
Recife 13
Tashkent 13
Düsseldorf 12
Sorocaba 12
Goiânia 11
Ribeirão Preto 11
São José dos Campos 11
Alghero 10
Brussels 10
Contagem 10
Dallas 10
Romola 10
Toronto 10
Baghdad 9
Bishkek 9
Istanbul 9
Jacksonville 9
Santo André 9
Cagliari 8
Dhaka 8
Duque de Caxias 8
Florianópolis 8
Guayaquil 8
João Pessoa 8
Lahore 8
Mountain View 8
Nova Iguaçu 8
Osasco 8
Ottawa 8
São Luís 8
Baku 7
Hortolândia 7
Ipatinga 7
Lappeenranta 7
Piracicaba 7
Portsmouth 7
Turin 7
Uberlândia 7
Vienna 7
Amman 6
Ankara 6
Barbacena 6
Barbianello 6
Cape Town 6
Caruaru 6
Cuiabá 6
Dublin 6
Feira de Santana 6
Joinville 6
Lauterbourg 6
Manaus 6
Presidente Prudente 6
Ribeirão das Neves 6
Santa Luzia 6
Santa Maria 6
São João del Rei 6
Tel Aviv 6
Americana 5
Ann Arbor 5
Belgrade 5
Betim 5
Campo Grande 5
Caracas 5
Casablanca 5
Council Bluffs 5
Florence 5
Johannesburg 5
Lima 5
London 5
Montevideo 5
Nairobi 5
Totale 2.530
Salva come PNG Salva come JPEG
Nome #
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 194
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 96
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 95
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 87
A case of vasculitis-like skin eruption associated with COVID-19 87
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 87
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 85
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 84
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 82
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 72
High-risk sexual behavior and HIV/STDs cascade of care in migrants: Results from an Italian dedicated outpatient clinic 72
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 72
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 71
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 70
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 69
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 68
Coronavirus disease 2019 (COVID-19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus-2 (SARS-CoV-2) Omicron variant 68
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 67
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? 67
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 67
Bone safety of dolutegravir-containing regimens in people living with HIV: Results from a real-world cohort 66
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 62
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 62
Early combination treatment with existing HIV antivirals: An effective treatment for COVID-19? 62
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 62
Is oral antibiotic therapy as effective as intravenous treatment in bacterial osteomyelitis? A real-life experience 57
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 57
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 56
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort study 56
Severity of lung involvement on chest x-rays in sars-coronavirus-2 infected patients as a possible tool to predict clinical progression: An observational retrospective analysis of the relationship between radiological, clinical, and laboratory data 55
Editorial - HIV and cancer during COVID-19 pandemic: Sailing through the perfect storm 55
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes 54
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease 51
Human urogenital schistosomiasis in West and Sub-Saharan Africa migrants in Sardinia, Italy: A retrospective monocentric study 51
The The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients 51
Infectious diseases screening approach among refugees: Results from a single-center study 51
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study 50
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 50
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 50
Quick diagnosis, staging, and treatment of HCV infection among people living in prison: Opinion expert panel 49
Recovery from olfactory and gustatory dysfunction following COVID-19 acquired during Omicron BA.1 wave in Italy 49
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 49
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 48
Quick diagnostic approach for HIV/STDs among migrants: results from a monocentric Italian cohort 48
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 48
Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort 48
The role of routine 131I-SPECT/CT use in differentiated thyroid carcinoma (DTC) follow-up 48
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 48
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 48
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression 47
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 47
HBV in Italian Women’s Jail: An Underestimated Problem? 47
Women Living with HIV in Italian Prison Settings: Results from the Gender-Specific ROSE Network 46
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience 46
What do We Know about Cryptic Aspergillosis? 45
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 45
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 44
HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects 43
Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen 43
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study 42
Prognostic role of the risk factors in the follow-up of T1B-T2 papillary thyroid carcinoma (PC) 42
Living with HIV and Getting Vaccinated: A Narrative Review 42
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter? 42
New score to predict COVID-19 progression in vaccine and early treatment era: the COVID-19 Sardinian Progression Score (CSPS) 41
The current and future off-label uses of dalbavancin: a narrative review 40
New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature 40
Emerging Clinical Features of COVID-19 Related Pancreatitis: Case Reports and Review of the Literature 39
Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments 38
Sexually Transmitted Infections Prevalence and Cascade of Care among Undocumented Sex Workers: A Twenty-Year-Long Experience 37
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations 36
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study 36
In Response to Smell and Taste Loss in COVID-19 After Complete Vaccination: Correspondence 36
Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the ICONA network 35
Knowledge, Attitudes, and Practices toward Antimicrobial Resistance among Young Italian Nurses and Students: A Multicenter, Cross-Sectional Study 35
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned? 35
Treatment Experienced People Living With HIV switching to DOR/3TC/TDF in Outpatient Setting: Real-World Data on Tolerability and Cost Savings From an Italian Multicenter Cohort 34
Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study 33
The high burden of pediatric cystic echinococcosis in Kazakhstan: epidemiological and clinical consequences 33
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up 32
Special Issue "Efficacy and Safety of Antiviral Therapy" 30
Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding 29
Efficacy and Safety of Ceftazidime–Avibactam Alone versus Ceftazidime–Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort 28
Perspectives on climate action and the changing burden of infectious diseases among young Italian doctors and students: a national survey 28
Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era 28
SARS-CoV-2 Vaccination Among Incarcerated People: A Barrier to Overcome 28
null 28
Reply letter - “Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: A nationwide comparative analysis” 28
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 27
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study 27
Viral Hepatitis C New Microelimination Pathways Objective: Psychiatric Communities HCV Free 27
Shedding new light on COVID-19 therapeutics during the omicron era: a deeper dive into real-world data 26
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 26
Incidence and burden of long COVID in Africa: a systematic review and meta-analysis 26
The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up 24
New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete Vaccination 23
Enhancing AI Chatbot Responses in Health Care: The SMART Prompt Structure in Head and Neck Surgery 20
Exploring the Impact of Cabotegravir-Rilpivirine Long-Acting on Weight Gain, Body Composition, and Quality of Life in Adults Living with HIV 14
The impact of risk factors ascertained at the surgery of the primary tumor on metastasis appearance and outcome of patients with papillary thyroid microcarcinoma (PTMC). 7
Totale 4.876
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.401
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 4 0
2020/2021138 2 3 14 0 9 16 10 23 44 17 0 0
2021/2022177 4 4 5 1 1 4 1 5 8 18 41 85
2022/2023646 44 74 20 96 47 97 25 80 97 15 39 12
2023/2024535 38 28 20 27 194 92 4 7 2 5 34 84
2024/20253.371 50 36 183 137 161 155 392 653 1.150 454 0 0
Totale 4.876